Relmada Therapeutics
RLMD
#8408
Rank
C$0.40 B
Marketcap
C$3.76
Share price
-15.76%
Change (1 day)
-37.61%
Change (1 year)

EPS for Relmada Therapeutics (RLMD)

EPS in 2026 (TTM): C-$1.29

According to Relmada Therapeutics's latest financial reports the company's current EPS (TTM) is C-$1.33. In 2025 the company made an earnings per share (EPS) of C-$2.08 an increase over its 2024 EPS that were of C-$3.80.

EPS history for Relmada Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.29-38.05%
2025C-$2.08-45.28%
2024C-$3.80-19.21%
2023C-$4.70-38.11%
2022C-$7.60-25.98%
2021C-$10.2787.93%
2020C-$5.4639.05%
2019C-$3.93-4.2%
2018C-$4.1037.5%
2017C-$2.98100%
2016C-$1.49-87.56%
2015C-$11.99
2013C-$0.04530273.48%
2012C-$0.01213

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cytokinetics
CYTK
C-$8.66 549.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
C$1.75-231.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel